The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
Bryan A. Ward, Jude Christopher Gorski, David R. Jones et al. · Journal of Pharmacology and Experimental Therapeutics · 2003
Cited by 636